Abstract
Transforming growth factor-β (TGF-β) stimulates cellular proliferation and transformation to a myofibroblast phenotype in vivo and in a subset of fibroblast cell lines. As the Smad pathway is activated by TGF-β in essentially all cell types, it is unlikely to be the sole mediator of cell type-specific outcomes to TGF-β stimulation. In the current study, we determined that TGF-β receptor signaling activates phosphatidylinositol 3-kinase (PI3K) in several fibroblast but not epithelial cultures independently of Smad2 and Smad3. PI3K activation occurs in the presence of dominant-negative dynamin and is required for p21-activated kinase-2 kinase activity and the increased proliferation and morphologic change induced by TGF-β in vitro.
Original language | English (US) |
---|---|
Pages (from-to) | 10431-10440 |
Number of pages | 10 |
Journal | Cancer research |
Volume | 65 |
Issue number | 22 |
DOIs | |
State | Published - Nov 15 2005 |
ASJC Scopus subject areas
- Oncology
- Cancer Research